RICOVR HEALTHCARE INC.

PRINCETON, NJ · Founded 2018 · Medtech · Private

Plasmonic fiber optic absorbance biosensor (P-FAB) technology integrated into an automated point-of-care device (XALIVA®) that quantifies THC in saliva using gold nanoparticle immunoassay

Claim this profile

Follows are private to you and power your alerts

Updated · ricovr.com

Sector
Medtech
Headquarters
PRINCETON, NJ
Founded
2018
Latest Form D
$550K, Jan 2026
Total capital
$7.4M
Federal grants
$646K
3 awards · 2024–2025
Rank in peer group#116 of 445
Private capital raised
$6.7M
7 Form D · last Jan 2026
9 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
1 pending · first 2026
Rank in peer group#109 of 445

Capital timeline

2020202120222023202420252026FEDERAL ↑EQUITY ↓Cumulative $7.4M$296K$296K$54K5th Form D$833K6th Form D$2M7th Form D$550K
2020202220242026FEDERAL ↑EQUITY ↓Cumulative $7.4M$296K$296K6th Form D$2M

Latest events

  • Private capital raisedForm D · SEC · 7th filing$550K
  • Federal grantHealth and Human S · Phase I · Advancement of a Point-of-Need (PoN) platform device for accurate and destigmatized detection of recent cannabis use$54K
  • Federal grantHealth and Human S · Phase I · Quantitative measurement of PlGF using a rapid, low-cost, point-of-care (POC) diagnostic platform for prediction and detection of pre-eclampsia$296K
  • Federal grantHealth and Human S · Phase I · Advancement of a Point-of-Need (PoN) platform device for accurate and destigmatized detection of recent cannabis use$296K
  • Private capital raisedForm D · SEC · 6th filing$2M
  • Private capital raisedForm D · SEC · 5th filing$833K
  • Private capital raisedForm D · SEC · 4th filing$255K
  • Private capital raisedForm D · SEC · 3rd filing$2.2M
  • Private capital raisedForm D · SEC · 2nd filing$535K
  • Private capital raisedForm D · SEC · 1st filing$300K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 445 peers

Line = median

Medtech · Device

  • Federal grants#116 · top 26%
  • Granted patents#109 · top 24%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Andrew DowiczDirectorNamed in SEC Form D filings
  • Himanshu BhatiaExecutive Officer, Director, PromoterNamed in SEC Form D filings
  • Piyush SadanaDirectorNamed in SEC Form D filings
  • Steven ShumanDirectorNamed in SEC Form D filings
  • Steve ShumanDirectorNamed in SEC Form D filings
  • Vikas DesaiDirectorNamed in SEC Form D filings
Show all 7 people
  • William HagamanDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 2

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .